top of page


News & Exhibitions
- ultra compact tablet press - personalised tablets and/or tablet development


Exciting Update: A New Milestone with Our Partner NORTEC Pharma!
We’re thrilled to announce that we’ve reached another important stage in our collaboration with NORTEC Pharma.🎉 Take a look at the four...
Sep 30, 20241 min read
3D Tablet Printer vs PrivMed®: Which makes the better swallowable tablet?
*The grey sample tablet in this video was produced with a commercially available 3D printer for demonstration purpose #nextgenmedication...
Mar 13, 20241 min read
Personalised tablet production like magic!
#nextgenmedication #personalizedmedicine #health #innovation #3dprinting
Mar 5, 20241 min read
Speed matters, how much faster is PrivMed® compared to a 3D tablet printer ?
#nextgenmedication #personalizedmedicine #health #innovation #3dprinting
Feb 27, 20241 min read


The inevitable dead end of 3D printers in personalised medication
#nextgenmedication #personalizedmedicine #health #innovation #3dprinting
Feb 22, 20241 min read


Why are medications still predominantly manufactured in mass production?
Are patients not individuals with very different needs? The future of disease treatment lies in personalised medication. Yet, in one of...
Feb 15, 20241 min read


Driving Innovation Together
PrivMed® X AB and ACG World, two distinguished names in the realm of pharmaceutical innovation, have come together to embark on a journey...
Sep 1, 20231 min read


For PrivMed® traveling, 5 cities (EU/USA) in 5 days....
On tour for PrivMed® X AB Today I'm going to take you on a typical business trip like I've been doing for over 20 years. If you are...
Jun 22, 20233 min read


Can you imagine doing tablet development on a tablet press:
- so compact, that it fits on any table ? - so versatile, that it's capable to produce single, bi- AND tri-layer tablets ? - so unique,...
Jun 13, 20231 min read


Our new brochure of PrivMed® X and Paracelsus®
New generation of our ultra compact tablet press with the unique weight-controlled dosing system PrivMed® Paracelsus® - for fully...
Apr 20, 20231 min read
Our new facilities in Schlierbach/Baden-Württemberg
We moved into our new facilities: PrivMed® GmbH Siemensstr. 28 DE-73278 Schlierbach Germany Video tour demo room: Google coordinates:...
Apr 2, 20231 min read


Parlametric's survey for PrivMed®
Healthcare professionals’ thoughts on personalised medicine Personalised medication in pharmacies/clinical pharmacies You want to learn...
Dec 16, 20221 min read


EXPOPHARM Interview with Inga Bergen
PrivMed® was selected as one of the exhibition highlights at EXPOPHARM Munich, 2022. We were very happy about this special honor and of...
Sep 20, 20221 min read


PrivMed® @ expopharm 14 – 17th Sept. 2022 in Munich
PrivMed® GmbH presents itself to the public for the first time at expopharm 22 in Munich with the first PrivMed® Futorque IQ unit....
Sep 8, 20221 min read


We finished the pre-series model !
A milestone of the development and assmebly has been reached. In spite of the CoVid pandemic and in spite of the global part shortage, we...
Aug 13, 20221 min read


Cooperation Summit BdVAK 2020 in Munich
Invitation from Dr. Stefan Hartmann, President of the Bundesverband Deutscher Apothekenkooperationen e.V. (BdVAK) to give a presentation...
Feb 12, 20201 min read


Founding of PrivMed® GmbH
On Nov. 27th, 2029, PrivMed® GmbH, with its registered office in Baden-Württemberg and its founders Ingo Krause and René Manigk as...
Nov 27, 20191 min read


Building of the prototype
The technical design of PrivMed® is completed and work on the prototype begins. It is a very exciting time for our team, filled with...
Oct 1, 20191 min read


The Go-Inno funding
In July 2019, the German Federal Ministry for Economic Affairs and Energy (BMWi), in cooperation with the grant-verifying German...
Jul 9, 20191 min read


First nomination for the award of PrivMed®
Nomination of PrivMed® for the "Vision A Awards" of the pharmacy online portal www.apotheke-adhoc.de www.apotheke-adhoc.de/nachrichten/…p...
Mar 20, 20191 min read
bottom of page